Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam …

JE Semple, DC Rowley, TK Brunck…

Index: Journal of Medicinal Chemistry, , vol. 39, # 23 p. 4531 - 4536

Full Text: HTML

Citation Number: 78

Abstract

... Journal of Medicinal Chemistry. ... Corvas International, Inc., 3030 Science Park Road, San Diego, California 92121-1102, and Department of Chemistry, Michigan State University, East Lansing, Michigan 48824-1322. J. Med. Chem. ...

Related Articles:

Potent and selective thrombin inhibitors featuring hydrophobic, basic P 3 P 4-aminoalkyllactam moieties

[Bioorganic and Medicinal Chemistry Letters, , vol. 8, # 24 p. 3525 - 3530]

Design, synthesis, and structure–Activity relationships of unsubstituted piperazinone-Based transition state factor Xa inhibitors

[Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 4 p. 723 - 728]

Design, synthesis, and structure–Activity relationships of unsubstituted piperazinone-Based transition state factor Xa inhibitors

[Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 4 p. 723 - 728]

More Articles...